Carlos Silva de Jesus

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy

José Carlos Couto-Fernandez, Carlos Silva de Jesus, Milene Alvarenga Rachid et al. · Memórias do Instituto Oswaldo Cruz · 2005 · 71 citations · Full text

Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis

Valéria C. Rolla, María Aparecida Vieira, Douglas Pereira Pinto et al. · Clinical Drug Investigation · 2006 · 29 citations

Pulmonary Tuberculosis, Rifampicin Combined Therapy, Treatment And Prevention +10

Transmitted drug resistance in patients with acute/recent HIV infection in Brazil

Ana C. Silvestre‐Ferreira, Lara E. Coelho, Eduarda Grinsztejn et al. · The Brazilian Journal of Infectious Diseases · 2017 · 29 citations · Full text

Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola

Cruz S. Sebastião, Zoraima Neto, Carlos Silva de Jesus et al. · PLoS ONE · 2019 · 19 citations · Full text

Genetics, Genetic Epidemiology, Hiv-1 Genetic Diversity +19

High HIV-1 Diversity and Prevalence of Transmitted Drug Resistance Among Antiretroviral-Naive HIV-Infected Pregnant Women from Rio de Janeiro, Brazil

Edson Delatorre, Carlos Silva de Jesus, José Carlos Couto-Fernandez et al. · AIDS Research and Human Retroviruses · 2016 · 17 citations

Immunology, Hiv-1 Pol Gene, Antiviral Drug +16